Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schnorr

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Urology|July 20, 1999
Re: Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samplesM Lein, K Jung, B Brux, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Metalloproteinases and tissue inhibitors of matrix-metalloproteinases in plasma of patients with prostate cancer and in prostate cancer tissueM Lein, L Nowak, K Jung, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 9, 2002
The novel synthetic inhibitor of matrix metalloproteinases Ro 28-2653 induces apoptosis in Dunning tumor cellsD Mangoldt, B Sinn, M Lein, et al.
The Journal of Urology|March 1, 1997
Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE)H H Schlechte, D Schnorr, T Löning, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 3, 2000
[MRI of the prostate after combined radiotherapy (afterloading and percutaneous): histopathologic correlation]D Beyersdorff, M Taupitz, S Deger, et al.
Clinical Chemistry|October 24, 2001
Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancerK Jung, M Lein, K von Hösslin, et al.
International Journal of Cancer|October 10, 1998
Matrix metalloproteinase-2 in blood does not indicate the progression of prostate cancerK Jung, C Laube, M Lein, et al.
Urology|January 14, 1999
Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests comparedK Jung, J Zachow, M Lein, et al.
Techniques in Urology|January 1, 1997
High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancerS Deger, S Dinges, J Roigas, et al.
Der Urologe. Ausg. A|February 28, 2003
[Renal carcinoma with invasion of the suprahepatic vena cava (Staehler stage III and IV): surgical treatment and results]J Roigas, A Wille, K Winter, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Urology|July 20, 1999
Re: Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samplesM Lein, K Jung, B Brux, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Metalloproteinases and tissue inhibitors of matrix-metalloproteinases in plasma of patients with prostate cancer and in prostate cancer tissueM Lein, L Nowak, K Jung, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 9, 2002
The novel synthetic inhibitor of matrix metalloproteinases Ro 28-2653 induces apoptosis in Dunning tumor cellsD Mangoldt, B Sinn, M Lein, et al.
The Journal of Urology|March 1, 1997
Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE)H H Schlechte, D Schnorr, T Löning, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 3, 2000
[MRI of the prostate after combined radiotherapy (afterloading and percutaneous): histopathologic correlation]D Beyersdorff, M Taupitz, S Deger, et al.
Clinical Chemistry|October 24, 2001
Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancerK Jung, M Lein, K von Hösslin, et al.
International Journal of Cancer|October 10, 1998
Matrix metalloproteinase-2 in blood does not indicate the progression of prostate cancerK Jung, C Laube, M Lein, et al.
Urology|January 14, 1999
Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests comparedK Jung, J Zachow, M Lein, et al.
Techniques in Urology|January 1, 1997
High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancerS Deger, S Dinges, J Roigas, et al.
Der Urologe. Ausg. A|February 28, 2003
[Renal carcinoma with invasion of the suprahepatic vena cava (Staehler stage III and IV): surgical treatment and results]J Roigas, A Wille, K Winter, et al.
Pageof 12